Dr. Vincent Miller is a world-expert in lung cancer and clinical trial design and interpretation. His role in collaborative research was critical to identifying certain EGFR mutations as the molecular basis of sensitivity and resistance to first-generation EGFR TKIs. Dr. Miller has previously served as Physician-in-Chief at EQRx and prior to that served as Chief Medical Officer at Foundation Medicine. Before joining the Foundation, Dr. Miller dedicated over 20 years to cancer patient care and research at Memorial Sloan Kettering Cancer Center. Among his many accolades, Dr. Miller received the American Cancer Society Clinical Oncology Career Development Award. He joined One’s board in March 2024.